Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Humabs BioMed S.A.
Description mAb which blocks an Ebola virus receptor
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationEbola
Indication DetailsTreat Ebola virus infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today